HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel therapeutic use of Versajet for intestinal mucormycosis.

Abstract
We describe the case of a 17-year-old boy who developed intestinal mucormycosis from Rhizophus oryzae (order Mucorales) following chemotherapy for the management of acute myeloid leukaemia. He underwent a hemicolectomy and further surgery utilising the pressure washing of Versajet to debride colonised fungal collections from the psoas muscle limiting the amount of surgical debridement needed.
AuthorsWilliam Calvert, Dhanya Mullassery, Rajeev Shukla, Graham Lamont
JournalBMJ case reports (BMJ Case Rep) Vol. 2014 (Mar 03 2014) ISSN: 1757-790X [Electronic] England
PMID24591385 (Publication Type: Case Reports, Journal Article)
Topics
  • Adolescent
  • Colonic Diseases (diagnosis, microbiology, surgery)
  • Debridement (instrumentation, methods)
  • Humans
  • Male
  • Mucormycosis (diagnosis, surgery)
  • Psoas Muscles
  • Rhizopus (isolation & purification)
  • Therapeutic Irrigation (instrumentation)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: